Synapse - Praneet K Kang

Praneet K Kang

Research Focus

Former Employee. Medicine; Medical Student Temporary

https://orcid.org/0000-0001-5989-3251

Recent additions – View all

Randomized phase II multicenter trial of abiraterone acetate with or without cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
Journal Article

Slovin, S. F.; Knudsen, K.; Halabi, S.; de Leeuw, R.; Shafi, A.; Kang, P.; Wolf, S.; Luo, B.; Gopalan, A.; Curley, T.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save
Immunomodulatory activity of a colony-stimulating factor-1 receptor inhibitor in patients with advanced refractory breast or prostate cancer: A phase I study
Journal Article

Autio, K. A.; Klebanoff, C. A.; Schaer, D.; Kauh, J. S. W.; Slovin, S. F.; Adamow, M.; Blinder, V. S.; Brahmachary, M.; Carlsen, M.; Comen, E.; more...
Clinical Cancer Research (2021)

Fulltext@MSK | Save
Abiraterone acetate (AA) with or without cabazitaxel (CBZ) in treatment of chemotherapy naive metastatic castration-resistant prostate cancer (mCRPC)
Meeting Abstract

Slovin, S. F.; Knudsen, K. E.; Halabi, S.; Fleming, M. T.; Molina, A. M.; Wolf, S. P.; de Leeuw, R.; Fernandez, C.; Kang, P.; Southwell, T.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Co-authors at MSK

3

Slovin
1

Adamow
1

Autio
1

Blinder
1

Comen
1

Danila
1

Durack
1

Fernandez
1

Fox
1

Gluskin
1

Gopalan
1

Klebanoff
1

Landa
1

Modi
1

Morris
1

Rathkopf
1

Sanford
1

Smart-C...
1

Wong

Types of Work

Publications

Journal of Clinical Oncology (2)
Clinical Cancer Research (1)